For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab64116? Please let us know so that we can cite the reference in this datasheet.
ab64116 has been referenced in 2 publications.
- Xu S et al. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat Commun 7:11406 (2016).
- Li Y & Ding J Optimized generation of survivin-specific cytotoxic T lymphocytes against lung cancer. Mol Med Rep 12:2169-74 (2015).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"